FDA puts Kezar lupus trial on hold after earlier report of patient deaths
Kezar Life Sciences’ autoimmune drug candidate has been put on hold by the FDA after the company said last week that four patients died in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
